Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.30 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21409797 | 0.85 | LMNA (0.34) | LTA4HMEN1KMT2AALDH1A1 | |
| SCHEMBL22654134 | 0.81 | SMN1; SMN2 (0.35) | ALDH1A1TP53 | |
| SCHEMBL22654303 | 0.79 | CA2 (0.36) | MEN1KMT2ATSHR | |
| SCHEMBL135716 | 0.77 | MEN1 (0.32) | RELAMEN1KMT2A | |
| SCHEMBL485788 | 0.77 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL580082 | 0.77 | ALDH1A1 (0.33) | TRPA1ALDH1A1TSHR | |
| SCHEMBL22654224 | 0.77 | MAPK1 (0.34) | MEN1KMT2AALDH1A1 | |
| SCHEMBL17239083 | 0.76 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL11493076 | 0.73 | ALDH1A1 (0.31) | ALDH1A1TSHR | |
| SCHEMBL27840477 | 0.73 | MAPK1 (0.32) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111253530-A | Composite polycarboxylic acid water reducing agent and preparation method thereof | 南通瑞特建筑材料有限公司 | 2020-06-09 | — | — | CN | claimed |
| CN-105837614-B | A kind of preparation method of methyl phenyl vinyl Ethoxysilane | 佛山市华联有机硅有限公司 | 2018-08-21 | — | — | CN | claimed |
| US-12609210-B2 | Curable composition and cured body of same | TOKUYAMA CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20230260669-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | TOKUYAMA CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| EP-4183579-A1 | CURABLE COMPOSITION AND CURED BODY OF SAME | Tokuyama Corporation (JP) | 2023-05-24 | — | — | EP | disclosed |
| CN-108003348-A | Siloxanes abutting ladder poly-siloxane, its preparation method and application | 长兴（中国）投资有限公司 | 2018-05-08 | — | — | CN | disclosed |
| CN-104955900-B | Curable composition containing polysiloxane and cured product thereof | 中央硝子株式会社 | 2017-03-15 | — | — | CN | disclosed |
| WO-2016193646-A1 | METHOD FOR IMPREGNATING A FIBROUS SUBSTRATE WITH A DISPERSION COMPRISING A METHACRYLIC POLYMER | ARKEMA FRANCE (FR) | 2016-12-08 | — | — | WO | disclosed |
| US-9512272-B2 | Curable composition containing silicone, and cured product thereof | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-12-06 | — | — | US | disclosed |
| CN-105837614-A | Preparation method of methylphenylvinylethoxysilane | 佛山市华联有机硅有限公司 | 2016-08-10 | — | — | CN | disclosed |
| US-20150322211-A1 | Curable Composition Containing Silicone, and Cured Product Thereof | CENTRAL GLASS COMPANY, LIMITED (JP) | 2015-11-12 | — | — | US | disclosed |
| CN-101024203-A | High-performance light catalyst loating solution and preparing method | TAEOH CO LTD (KR) | 2007-08-29 | — | — | CN | disclosed |
| US-20070197755-A1 | Silicon-containing curing composition and heat cured product thereof | ADEKA CORPORATION (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1801871-A1 | SEMICONDUCTOR DEVICE | THE KANSAI ELECTRIC POWER CO., INC. (JP) | 2007-06-27 | — | — | EP | disclosed |
| CN-1930245-A | Silicon-containing curable composition and cured object obtained by thermally curing the same | ADEKA CORP (JP) | 2007-03-14 | — | — | CN | disclosed |
| EP-1746132-A1 | SILICON-CONTAINING CURABLE COMPOSITION AND CURED OBJECT OBTAINED BY THERMALLY CURING THE SAME | Adeka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1293522-B1 | CURABLE COMPOSITION COMPRISING PHOTOCHROMIC COMPOUND | TOKUYAMA CORP (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-6802993-B2 | POLYFUNCTIONAL ACRYLATE MONOMER, A SECOND RADICALLY POLYMERIZABLE MONOMER HAVING A SILANOL GROUP FOR EXCELLENT ADHESION TO A HARD COAT, AND A THIRD MONOMER; HIGH COLOR DENSITY AND FADING SPEED; PLASTIC LENSES | TOKUYAMA CORPORATION (JP) | 2004-10-12 | — | — | US | disclosed |
| EP-1293522-A1 | CURABLE COMPOSITION COMPRISING PHOTOCHROMIC COMPOUND | TOKUYAMA CORPORATION (JP) | 2003-03-19 | — | — | EP | disclosed |
| US-20030036579-A1 | Curable composition comprising a photochromic compound | TOKUYAMA CORPORATION (JP) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12609210-B2 | Curable composition and cured body of same | UACA, MMAB, SMCHD1 | RELA 41/4885LTA4H 1968/4885MEN1 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.